HIGHLIGHTS
- who: Mark B. Carascal et al. from the Pathogen-Host-Environment Interactions Research Laboratory, Institute of Biology, College of Science, University of the IGY Life Sciences, Canada have published the paper: Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response, in the Journal: (JOURNAL) of March/18,/2022
- what: The aim of this review paper was to highlight current progress and advancements in RIV development, focusing on the properties of the different influenza targets, current production platforms, and evidence of inducing heterosubtypic immunity. Efforts to enhance and fast-track the research in this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.